INS and type 2 diabetes mellitus: The initial decision to start insulin therapy is usually based upon clinical guideline recommendations and other patient-related factors including body mass index (BMI), age, duration of T2DM, complications of T2DM, and target glycated haemoglobin (HbA1c).